Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
RXO (NYSE:RXO) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.04 by 72.22 per...
Stifel analyst J. Bruce Chan maintains RXO (NYSE:RXO) with a Hold and raises the price target from $14 to $17.
Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $17 to $15.
JP Morgan analyst Brian Ossenbeck maintains RXO (NYSE:RXO) with a Underweight and raises the price target from $15 to $16.
UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $15 to $17.
